Listing #8057121 oncnursingnews.com
338
oncnursingnews.com
More Listing
The FDA granted a priority review for a Biologics License Application (BLA) to
bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...
Category
Website Performance
| observedDomContentLoadedTs | 652618221032 |
| observedLargestContentfulPaint | 1.13 Sec |
| largestContentfulPaint | 4.49 Sec |
| observedDomContentLoaded | 0.27 Sec |
| observedLargestContentfulPaintTs | 652619078506 |
| observedFirstPaint | 0.3 Sec |
| interactive | 6.99 Sec |
| observedTraceEnd | 8.28 Sec |
| observedFirstMeaningfulPaintTs | 652619078506 |
| observedTimeOrigin | 0 Sec |
| observedNavigationStartTs | 652617946577 |
| observedFirstContentfulPaint | 0.3 Sec |
| observedSpeedIndexTs | 652620133484 |
| observedTimeOriginTs | 652617946577 |
| observedLastVisualChangeTs | 652623776577 |
| observedTraceEndTs | 652626230025 |
| observedFirstContentfulPaintAllFramesTs | 652618242304 |
| observedFirstPaintTs | 652618242304 |
| observedLargestContentfulPaintAllFrames | 1.13 Sec |
| totalBlockingTime | 0.57 Sec |
| observedLastVisualChange | 5.83 Sec |
| firstContentfulPaint | 0.79 Sec |
| firstMeaningfulPaint | 2.3 Sec |
| totalCumulativeLayoutShift | 0 Sec |
| observedFirstVisualChange | 0.46 Sec |
| observedLoad | 3.23 Sec |
| maxPotentialFID | 0.22 Sec |
| observedNavigationStart | 0 Sec |
| observedFirstContentfulPaintAllFrames | 0.3 Sec |
| observedFirstMeaningfulPaint | 1.13 Sec |
| observedFirstVisualChangeTs | 652618410577 |
| cumulativeLayoutShift | 0 Sec |
| observedLoadTs | 652621173253 |
| speedIndex | 3.73 Sec |
| observedTotalCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaintTs | 652618242304 |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| observedSpeedIndex | 2.19 Sec |
| observedCumulativeLayoutShift | 0 Sec |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedLargestContentfulPaintAllFramesTs | 652619078506 |
